Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Cell Reports|April 12, 2023
Conformational changes in the negative arm of the circadian clock correlate with dynamic interactomes involved in post-transcriptional regulationJacqueline F Pelham, Alexander E Mosier, Samuel C Altshuler, et al.
The Laryngoscope|December 2, 2016
Predictors of outcome with cetuximab and paclitaxel for head and neck squamous cell carcinomaBruna Pellini Ferreira, Mary Redman, Kelsey K Baker, et al.
Scientific Reports|October 22, 2025
Anti-VEGF neutralizing antibody delays osteomucosal healing by reducing collagen formation in miceEun-Bin Bae, Moon-Young Kim, Suk Ji, et al.
The Plant Cell|December 30, 2025
Polymerization-mediated SRFR1 condensation in upper lateral root cap cells regulates root growthJianbin Su, Xianjin Xu, Joshua S Baik, et al.
American Journal of Clinical Oncology|February 13, 2014
Adjuvant Radiotherapy for Stages II and III Resected Thymoma: A Single-institutional ExperienceJinchun Yan, Qin Liu, Jessica N Moseley, et al.
JCO Clinical Cancer Informatics|May 7, 2019
Validity of Natural Language Processing for Ascertainment of <i>EGFR</i> and <i>ALK</i> Test Results in SEER Cases of Stage IV Non-Small-Cell Lung CancerBernardo Haddock Lobo Goulart, Emily T Silgard, Christina S Baik, et al.
JTO Clinical and Research Reports|May 20, 2022
Clinical Outcomes With Dabrafenib Plus Trametinib in a Clinical Trial Versus Real-World Standard of Care in Patients With <i>BRAF</i>-Mutated Advanced NSCLCBruce E Johnson, Christina S Baik, Julien Mazieres, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2019
A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland CancerCristina P Rodriguez, Qian Vicky Wu, Jenna Voutsinas, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Real-world treatment patterns and survival of patients with BRAF V600-mutated metastatic non-small cell lung cancerLeora Horn, Joshua Bauml, Patrick M Forde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2016
Phase Ib Trial of the Toll-like Receptor 8 Agonist, Motolimod (VTX-2337), Combined with Cetuximab in Patients with Recurrent or Metastatic SCCHNLaura Q M Chow, Chihiro Morishima, Keith D Eaton, et al.
Pageof 12